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Abstract 
In this work, human mesenchymal stem cells (hMSCs) and their osteogenically precultured 
derivatives were directly co-cultured with human umbilical vein endothelial cells (HUVECs) on 
electrospun 3D poly(-caprolactone) microfiber scaffolds in order to evaluate the co-culture’s 
effect on the generation of osteogenic constructs. Specifically, cells were cultured on scaffolds 
for up to three weeks, and the cellularity, alkaline phosphatase activity (ALP), and bone-like 
matrix formation were assessed. Constructs with co-cultures and monocultures had almost 
identical cellularity after the first week, however lower cellularity was observed in co-cultures 
compared to monocultures during the subsequent two weeks of culture. Scaffolds with co-
cultures showed significantly higher ALP activity, glycosaminoglycan and collagen production, 
as well as greater calcium deposition over the course of study compared to monocultures of 
hMSCs. Furthermore, the osteogenic outcome was equally robust in co-cultures containing 
osteogenically precultured and non-precultured hMSCs. The results demonstrate that the 
combination of MSC and HUVEC populations within a porous scaffold material under 
osteogenic culture conditions is an effective strategy to promote osteogenesis. 
 
Keywords: Bone tissue engineering; co-culture; mesenchymal stem cells; human umbilical vein 
endothelial cells; 3D culture; scaffold. 
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Introduction 
 
A major challenge in current bone tissue engineering strategies is the lack of vascular ingrowth.
1-
3
 Native bone tissue has an abundant vascular network, without which engineered tissue must 
rely primarily on diffusion for oxygen and nutrient transport, which is effective only over 
distances of 100 to 200 μm.4 One strategy for improving the survival and osteogenesis of tissue 
engineered bone grafts involves the addition of endothelial cells (ECs) to cultures containing 
mesenchymal stem cells (MSCs).
5-6
 MSCs are promising candidates for tissue engineering 
applications
7-8
 because they have a capacity to differentiate along bone, cartilage and adipose 
lineages.
9-12
 Additionally, MSCs reside in the bone marrow perivascular niche,
13-14
 which would 
facilitate paracrine communication between MSCs and ECs. Studies evaluating the use of ECs in 
MSC or osteoblast cultures have observed the formation of microvessels in the engineered 
construct.
15-19
  
Furthermore, previous studies have demonstrated that ECs are capable of enhancing the 
proliferation and osteogenic differentiation of MSCs.
20-24
 Thus, co-cultures of MSCs and ECs are 
currently being investigated for their ability to enhance bone-formation and have shown that 
trophic regulation from ECs can provide necessary components for MSC osteogenic 
differentiation.
5-6
 The addition of ECs to MSC or osteoblast cultures has been shown to enhance 
both pro-angiogenic and pro-osteogenic gene expression, stimulate alkaline phosphatase (ALP) 
activity, and increase mineralization.
15-17, 20-23, 25-27
 While numerous studies have evaluated such 
co-cultures in two dimensions, data obtained from 3D conditions are still very limited, as studies 
emphasizing the osteogenic outcome have primarily been performed in monolayer
19, 21, 23-24
 or 
pellet cultures
20, 22, 26
 but not on porous scaffolds. Studies performed with co-cultures of ECs and 
bone-forming cells on porous scaffolds have investigated primary osteoblasts
16-17, 28
 or an 
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osteoblast cancer cell line,
27-28
 and have focused on the survival of the ECs,
28
 angiogenic gene 
expression, the development of scaffold vascularization with ECs
16-17, 28
 or the properties of the 
scaffold material,
27
 but not on the osteogenic differentiation of bone forming cells (e.g., by 
quantifying bone-like matrix production and maturation). As such, previous co-culture studies 
have often utilized culture conditions favoring the angiogenic,
16-17, 27-28
 over the osteogenic 
outcome.  
A variety of scaffold materials have been investigated for EC and MSC co-cultures, including: 
poly(ε-caprolactone) (PCL); starch-based scaffolds with a fiber size of more than 200 µm,16, 17 
hydroxyapatite (HA) and β-TCP (Ca3(PO4)2) porous discs,
28
 hydrophilic and hydrophobic 
titanium surfaces,
27
 collagen mesh scaffolds,
29
 and poly(ε-caprolactone) (PCL)-hydroxyapatite 
(HA) composite membranes.
30 Recently, porous microfiber mesh scaffolds made of 
biodegradable PCL have been developed using electrospinning.
31
 Electrospun PCL scaffolds 
with 5 or 10 µm fiber diameters used in our laboratory have been shown to successfully support 
MSC proliferation and osteogenic differentiation.
32-33
  
In this study, it was hypothesized that co-cultures of human MSCs (hMSCs) and/or 
osteogenically precultured hMSCs and human umbilical vein endothelial cells (HUVECs) on 3D 
scaffolds would lead to enhanced osteogenesis over hMSCs or their derivatives alone. In order to 
test this hypothesis, hMSCs were co-cultured with HUVECs on electrospun PCL microfiber 
scaffolds under osteogenic culture conditions, and the effect on osteogenic differentiation was 
quantified with a variety of biochemical assays.  
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Materials and Methods 
Experimental design   
This study investigated a total of 8 groups, seeded onto electrospun PCL scaffolds and cultured 
in osteogenic medium for 7, 14, or 21 days. Three co-culture groups were investigated with the 
total number of cells used to seed each scaffold remaining constant (3.0x10
5 
cells per scaffold). 
In the first group, hMSCs and HUVECs were cultured in a 1:1 ratio (MH). In the second group, 
hMSCs were precultured for 7 days in osteogenic medium before being combined at a 1:1 ratio 
with HUVECs (OH). In the third group, hMSCs, osteogenically precultured for 7 days, were 
mixed with non-precultured hMSCs and HUVECs at a 1:1:1 ratio (OMH). Additionally, five 
monoculture groups were investigated, which consisted of: a high density (3.0x10
5 
cells per 
scaffold) of hMSCs with the same total number of cells as the co-culture (M2), a high density 
(3.0x10
5 
cells per scaffold) of osteogenically pre-cultured hMSCs (O2); a low density (1.5x10
5 
cells per scaffold) of hMSCs with the same total number of hMSCs as the co-culture groups 
(M1); a low density (1.5x10
5 
cells per scaffold) of osteogenically pre-cultured hMSCs (O1); and 
a monoculture of HUVECs at a density of 1.5x10
5 
cells per scaffold (H). 
Human mesenchymal stem cell culture and human umbilical vein endothelial cell culture 
Frozen bone marrow-derived hMSCs were kindly provided by Dr. Darwin Prockop of the Texas 
A&M University System Health Science Center in Temple, Texas, USA. A specification 
certificate provided with the cells indicated that they possessed widely accepted CD-markers, 
including CD90, CD105 and CD73
12
 and were tested for the capability to differentiate towards 
osteogenic and adipogenic lineages until passage 4. The hMSCs were thawed and cultured for 1-
2 passages in general expansion medium: α-MEM without nucleosides and ribonucleosides 
(Gibco, Grand Island, NY) with 13% v/v fetal bovine serum (FBS, Atlanta Biologicals, 
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Norcross, GA), 100 units/mL penicillin, 100 µg/mL streptomycin (Gibco, Grand Island, NY) and 
2-4 mM L-glutamine (Sigma, St. Louis, MO). Osteogenically pre-cultured cells were expanded 
for 1 passage in general media and an additional 7 days in osteogenic medium containing 10 nM 
dexamethasone, 10 mM β-glycerol-phosphate and 0.2 mM ascorbic acid (all from Sigma, St. 
Louis, MO). Cells at passage 3 were used for this study.   
Frozen, pooled, primary HUVECs, (ATCC, Manassas, VA) that were certified by the vendor as 
von Willebrand factor positive and smooth muscle α-actin negative were expanded prior to use 
in our studies. The HUVECs were thawed and cultured in Vascular Cell Basal Medium 
containing 0.2% bovine brain extract (BBE), 5 ng/ml recombinant human epidermal growth 
factor (rhEGF), 10 mM L-glutamine, 0.75 units/ml heparin sulfate, 1 µg/ml hydrocortisone, 50 
µg/ml ascorbic acid, 2% v/v FBS (Endothelial Cell Growth Kit-BBE) (all from ATCC, 
Manassas, VA) and 10 units/ml penicillin, 10 µg/ml streptomycin and 25 ng/ml amphotericin B 
(Gibco, Grand Island, NY). Cells at passage 4 were used for this study. 
Scaffold fabrication and characterization 
Nonwoven poly(ε-caprolactone) (PCL) microfiber mats were fabricated using a horizontal 
electrospinning apparatus as previously described.
31
 Mats were electrospun to achieve an average 
fiber diameter of ~10 µm using 18 wt % PCL (inherent viscosity 1.0-1.3 dl/g; Lactel, 
Birmingham, AL) in a solution of 5:1 v/v chloroform:methanol. The resulting PCL mats of ~1 
mm thickness were stored in a desiccator until use. Five PCL microfiber mats were electrospun 
to generate a sufficient number of discoid scaffolds for this study (average scaffold thickness 
1.05±0.05 mm). For cell seeding, discoid PCL scaffolds 8 mm in diameter were punched from 
the electrospun mats using a dermal biopsy punch (Miltex, Inc. York, PA), and the microfiber 
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morphology was assessed via scanning electron microscopy (SEM) (mean diameter 10.6±1.6 
µm). The scaffolds were then sterilized by exposure to ethylene oxide (AN74i, Andersen 
Sterilizers, Haw River, NC) at room temperature for 14 h and aerated overnight.  
Cell seeding of scaffolds 
 
To facilitate cell adhesion, pre-wetting of scaffolds was performed in a gradient series of ethanol 
(100%-25%; centrifugation for 15 min each step at 2000 rpm), followed by two rinses in 
phosphate buffered saline (PBS) and one rinse in general expansion medium. Scaffolds were 
maintained in culture medium overnight at 37°C prior to cell seeding. Pre-wetted scaffolds were 
press-fitted into polymethylmethacrylate cylindrical holders specifically designed to fit the 8 mm 
scaffolds and localize the cell suspension above the scaffolds for the time required for cell 
adhesion. Cell suspensions were slowly pipetted onto the scaffolds at a density of 1.5x10
5
 cells 
per scaffold for monocultures of hMSCs (M1), preosteoblasts (O1) and pure HUVECs (H) or 
3.0x10
5
 cells per scaffold for monocultures of hMSCs (M2), preosteoblasts (O2) and co-cultures 
(MH, OH, and OMH) in 200 µl of culture medium and allowed to adhere for 4 h before general 
expansion medium was added to completely fill the holders. Scaffolds were transferred after 24 h 
into 12-well culture plates (Becton Dickinson, Franklin Lake, NJ) with 3 ml of fresh osteogenic 
medium. Thereafter, medium was changed twice a week for up to 21 days. Four scaffolds from 
each group were harvested the day after seeding to assess the initial cellularity and ALP-activity 
(day 1). Twelve scaffolds from each experimental cellular group were harvested after 7, 14 and 
21 days of culture. 
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Biochemical assays 
After harvesting, the constructs were washed with PBS and frozen at -20°C until use for the 
biochemical assays. For extraction of DNA, GAG and collagen, thawed samples were digested in 
500 ml of proteinase K solution (1 mg/ml proteinase K, 0.01 mg/ml pepstatin A and 0.185 mg/ml 
iodoacetamide in a 50 mM tris-(hydroxymethyl-aminomethane) - 1mM ethylene-diamine-
tetraacetic acid buffer, pH 7.6) in a 56°C water bath for 16 h followed by two additional freeze-
thaw cycles and 10 min sonication. For measuring of alkaline phosphatase (ALP) activity and 
calcium (Ca) content, scaffolds were placed into 1 ml of milliQ water after thawing, and then 
subjected to two additional freeze-thaw cycles followed by 10 min sonication.
32
    
The DNA content of each cell lysate solution was quantified using the fluorometric PicoGreen 
assay (Invitrogen, Eugene, OR, USA) with an excitation wavelength of 490 nm and an emission 
wavelength of 520 nm (BioTek FLX800, Winooski, VT), as described elsewhere.
34-35
 ALP 
activity was performed according to an established colorimetric protocol.
35
 The ALP activity of 
samples was determined relative to a p-nitrophenol standard curve and presented as activity per 
scaffold. For measuring calcium content, each scaffold was removed from the aqueous cell 
lysates, placed into 1 ml 0.5 N acetic acid, and left on a shaker table at 200 rpm overnight to 
dissolve the calcium on the scaffolds. A colorimetric assay was used to quantify calcium content 
based on the color change that occurs when a calcium reagent (Arsenazo III, Diagnostic 
Chemicals, Oxford, CT) binds to free calcium.
32
 Glycosaminoglycan (GAG) content was 
determined using the colorimetric dimethylmethylene blue assay.
36
 GAG concentrations were 
determined relative to a chondroitin sulfate standard curve. Total collagen was extracted from 
scaffolds via basic hydrolysis of a 100 μl sample solution (obtained after proteinase K digestion) 
with 100 μl 4N NaOH for 20 min at 120°C. After cooling, samples were neutralized with acid, 
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and the resulting hydrolyzed collagen was determined by measuring hydroxyproline in a 
colorimetric assay as previously described.
37
 The resulting hydroxyproline concentrations were 
then converted to collagen contents for each scaffold following a 1:10 ratio of hydroxyproline to 
collagen.
32
 All colorimetric assays were performed on PowerWaveX340 Microplate Reader 
(BioTek Instruments, Winooski, VT). 
Histology 
At each time point two scaffolds from each group were rinsed with PBS and fixed in 10% neutral 
buffered formalin (Fisher Scientific, Pittsburgh, PA). Cryosections of 7 μm thickness were cut 
using a cryostat (Leica CM 1850 UV; Leica Biosystems Nussloch GmbH, Germany). Sections 
were stained with Safranin-O, von Kossa and Picrosirius red to visualize GAG, mineralized 
matrix and collagen fibers, respectively. Imaging was performed using a ZeissAxio Imager.Z2 
microscope (equipped with Axi-oCam MRc5; Carl Zeiss MicroImaging GmbH, Germany).  
Scanning electron microscopy 
Extracellular matrix morphology of cell-scaffold constructs was evaluated at each time point via 
scanning electron microscopy (SEM) (FEI Quanta 400 Environmental, Hillsboro, OR). Two 
scaffolds from each group were rinsed with PBS, fixed in 2.5% v/v glutaraldehyde in PBS for 30 
min at room temperature and dehydrated via an alcohol gradient (50%-100%) and dried 
overnight in ambient conditions.  
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Statistical analysis 
Results are presented as mean±standard deviation for n=4. The differences were analyzed using 
one-way ANOVA followed by Tukey’s post-hoc test using JMP 10 software package (SAS 
Institute, Cary, NC). Differences were considered significant at p<0.05. 
Results 
Scaffold cellularity 
As seen in Fig. 1, an increase in scaffold cellularity over time was observed in all monoculture 
groups (M1, O1, M2, O2), with the monoculture containing osteogenically precultured cells (O2) 
displaying the highest cellularity at day 14 and 21. All co-cultures containing HUVECs (OH, 
OMH, MH) were seeded with the same total number of cells as the high density monocultures 
(M2, O2). In the co-culture groups, cell proliferation took place primarily in the first 7 days. At 
14 days, DNA content in the co-cultures was significantly lower than either seeding density of 
the corresponding monocultures (O1 and O2 for OH and OMH; M1 and M2 for MH).  
ALP activity 
ALP activity generally peaked at day 7 and then decreased over time in the case of co-cultures 
(OH, OMH, MH). However, ALP activity remained relatively unchanged after day 7 for 
monocultures of non-precultured cells (M1, M2) and decreased in the osteogenically precultured 
monoculture groups at day 7 or later (O1, O2) (Fig. 2). Despite lower scaffold cellularity, all co-
cultures showed significantly higher total ALP activity per scaffold compared to the 
corresponding monocultures (O1 and O2 for OH and OMH; M1 and M2 for MH) from day 7 
onward (Fig. 2). The only exception was the co-culture group with mixed precultured and non-
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precultured hMSCs (OMH) and the monoculture group with osteogenically precultured cells at 
the higher seeding density (O2); these were not significantly different at day 21 (Fig. 2).  
Collagen synthesis 
All groups showed increasing collagen per scaffold, as seen in Fig. 3A, as well as collagen 
content normalized to DNA (Fig. 3B). In the co-cultures significantly increased collagen per 
scaffold was observed from day 14 to day 21. The co-cultures with osteogenically precultured 
cells (OH, OMH) had significantly increasing normalized collagen content during the first 14 
days of culture, whereas co-cultures with hMSCs (MH) showed significantly increased collagen 
normalized to DNA from day 14 to day 21. All co-cultures with either osteogenically precultured 
cells or hMSCs showed significantly higher collagen production per scaffold compared to all 
corresponding monocultures at day 7 of culture, as shown in Fig. 3A. The differences between 
groups were not significant at days 14 and 21, excluding the co-culture with hMSCs (MH), 
which presented a higher collagen content per scaffold in comparison to the hMSC monoculture 
with the lower seeding density (M1) at day 14. In contrast to total collagen content, normalized 
collagen content was significantly elevated for all co-culture groups compared to the 
corresponding monocultures at all investigated time points (Fig. 3B). Among the co-cultures, the 
highest collagen to DNA ratio was observed in the group with non-precultured cells (MH) at 
days 7 and 21.  
GAG synthesis 
All monocultures of either osteogenically precultured or non-precultured hMSCs (O1, O2 and 
M1, M2, respectively) showed continuously increasing GAG contents per scaffold, as seen in 
Fig. 4A. Co-cultures demonstrated completely different behavior in terms of GAG production 
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and synthetic activity. The GAG production per scaffold remained relatively unchanged with 
time for all co-cultures (Fig. 4A). GAG synthetic activity of cells significantly increased only 
from day 7 to day 14 in all investigated co-cultures (Fig. 4B). Total GAG production per scaffold 
over time was the strongest in the co-culture group with osteogenically precultured cells (OH) 
among all tested groups, whereas synthetic GAG activity (GAG/DNA) was similar between OH 
and OMH groups and was the strongest in the MH group at days 7 and 21. With regard to GAG 
to DNA ratio, all co-cultures had significantly higher synthetic activity in comparison to 
corresponding monocultures.  
Calcium deposition 
The amount of calcium deposited on scaffolds was minimal over time for all monoculture groups 
(Fig. 5). On the contrary, all investigated co-culture groups (OH, OMH, MH) had continuously 
increasing calcium deposition over time (Fig. 5). All co-cultures with either osteogenically 
precultured cells or hMSCs showed significantly higher calcium per scaffold compared to the 
corresponding monocultures at all tested time points, as shown in Fig. 5. There were no 
differences in calcium deposited between co-cultures with osteogenically precultured cells (OH) 
and hMSCs (MH) over time, but the co-culture with both cell types (OMH) showed the lowest 
calcium deposition per scaffold among these groups at days 7 and the highest at day 14.  
Histology 
Histology corroborated the results of calcium, collagen and GAG biochemical assays (Fig. 6). 
Histological analysis showed cells and extracellular matrix (ECM) accumulated near the top 
surface of the scaffolds, with increasing cellular penetration and matrix distribution with time. A 
clear difference between all co-cultures and monocultures was observed for calcium 
mineralization (Fig. 6). Specifically, co-cultures showed abundant deposits of mineralized matrix 
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that penetrated deeper into the scaffolds with time, while monocultures displayed relatively little 
mineral deposition. Similarly, the co-culture groups showed greater staining for GAGs relative to 
the monoculture groups (Fig. 6). The co-cultures also displayed more abundant collagen-rich 
matrix deposition, especially on the top scaffold surface (Fig. 6).  
Scanning electron microscopy 
SEM images (Supplementary Figure S1) generally showed extracellular matrix completely 
covering the scaffold surfaces and cells infiltrating the pores between PCL fibers, with the only 
exception being the HUVEC only group (H) (Supplementary Figure S2).  
Discussion 
The main objective of this study was to determine whether co-culturing hMSCs with 
endothelial cells on PCL microfiber scaffolds could enhance osteogenesis (as determined by 
ALP activity and calcium deposition) and the production of bone-like extracellular matrix 
components (as determined by collagen and GAG matrix production). HUVECs were selected 
for this study because they are an established model of endothelial cells and have been shown to 
stimulate osteogenesis in vitro.
20-23, 27
 General hMSC expansion medium with osteogenic 
supplements was used because of its proven ability to support osteogensis in co-cultures of 
HUVECs and hMSCs,
20
 as opposed to other media formulations that have demonstrated greater 
utility in maintaining and promoting angiogenesis of endothelial cells in co-culture.
17, 20, 28
. 
While the absence of angiogenic growth factors in osteogenic media limits endothelial cell 
metabolic activity and proliferation,
20
 it is still sufficient for manifestation of the angiogenic 
potential of HUVECs in co-cultures with hMSCs.
15, 20, 22
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From previous studies it is known that co-culturing endothelial cells with bone forming cells 
promotes cellular proliferation in 2D
21, 23
 as well as in 3D.
27
 However, since most of these 
findings were obtained using endothelial growth media, we evaluated the effect of 3D culture in 
osteogenic media. In the present study DNA content increased after 7 days of co-culture in 
osteogenic medium, but then decreased by 14 days. This is consistent with literature data where 
similar co-cultures led to a decrease in DNA content after 14 days of 2D-culture in osteogenic 
conditions.
20
 Indeed, the balance between cell proliferation and differentiation during 
development of the osteoblastic phenotype is well established.
38
 Consequently, the lower DNA 
content observed in co-cultures at 14 days relative to 7 days of culture could reflect a decrease in 
proliferation corresponding to osteogenic differentiation. This finding, together with the 
significantly increased ALP activity, as well as matrix production and maturation (collagen and 
GAG production and calcium deposition) observed in co-cultures at the earlier time points, 
supports the hypothesis that osteogenesis is enhanced in co-cultures of hMSCs and endothelial 
cells on microfiber scaffolds.          
The osteogenic preculture conditions used for the hMSCs in this study typically result in 
committed osteoprogenitor cells.
39
 In this study, it was observed that precultured and non-
precultured co-cultures presented ALP activity significantly higher than corresponding 
monocultures. The enhancement of ALP activity in co-cultures may be mediated by p38 
mitogen-activated protein kinase-dependent stabilization of mRNA for ALP.
40
 This type of 
stimulation has been shown in series of studies.
20-23, 25-27, 40
 One novel aspect of this study was 
that in addition to elevated ALP activity, all co-cultures were shown to have significantly higher 
production of the main non-mineral components of bone extracellular matrix, namely collagen 
and GAGs. The levels of these extracellular matrix components (as reflected by the collagen and 
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GAG contents of scaffolds normalized to DNA) in monocultures at each time point were always 
lower than those observed in co-cultures. The promotion of increased collagen matrix production 
by co-cultures is supported by several studies.
16, 23,
 
25
 For instance, up-regulated collagen type 1 
gene expression was found in co-cultures of human osteoblasts and dermal endothelial 
microvascular cells
16
 and in co-cultures of HUVECs and hMSCs.
23, 25
 However, no up-regulation 
in collagen expression was found in the co-culture of outgrowth endothelial cells and MSCs.
15
 
To our knowledge, no other studies have reported increased GAG production in co-cultures of 
MSCs and ECs in either 2D or 3D. GAGs have a variety of biological functions necessary for 
osteogenesis and cell-to-cell communications.
41
 One possible reason for increased GAG 
production observed in co-cultures in the present study could be residual heparin sulfate, which 
is a component of vascular basal media commonly used for HUVEC cultivation and the media 
used for HUVEC culture in the present study. However no GAGs were detected in HUVEC 
monoculture (Fig. 4) Interestingly, it is thought that heparan sulfate proteoglycans assist in 
mediating the interactions between marrow stromal cells and hematopoietic cells,
42-43
 and thus 
the upregulation of GAG production observed in the present study potentially could have further 
enhanced the effect of the co-cultures.     
Consistent with the results of biochemical and matrix production in general, all co-cultures 
presented increased mineralized matrix deposition compared to monocultures. This result was 
consistent with the observation in co-cultures of enhanced ALP activity, which hydrolyzes the 
phosphate source for mineralization, as well as increased collagen matrix production, which 
provides the structural support necessary for calcium deposition.
38
 The observed increased 
mineralization in co-cultures is consistent with literature data.
15, 20-21
 Furthermore, the very low 
calcium deposition found in monocultures is consistent with data obtained in a recent study in 
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which hMSCs from several donors demonstrated minimal calcium deposition for up to 28 days 
of culture, while co-cultures of HUVECs and hMSCs exhibited significant mineralized matrix 
much earlier in culture.
20
 This result emphasizes the role of endothelial cells as osteogenic 
mediators in co-culture models.   
To address the question of what stage of maturity favors the promotion of osteogenesis in 
this study, we tested three different co-cultures including two groups with a 1:1 ratio of either 
osteogenically precultured or non-precultured hMSCs together with HUVECs, as well as a third 
group combining all three cell types (OMH). The latter group was included in order to 
investigate the simultaneous cross-talk between various cell types that exist together in the bone 
marrow niche and to investigate the possibility of decreasing the number of HUVECs needed 
while maintaining a suitable osteogenic outcome. MSCs reside in the perivascular niche,
13-14
 and 
may be recruited to the site of bone regeneration by cues from endosteal (pre)osteoblasts as well 
as through signaling from the surrounding endothelium. Several studies investigating co-cultures 
of non-human MSCs with osteoblasts or osteoblast/osteocyte murine lines
44-45
 have shown the 
potential of directing osteogenic differentiation of MSCs in vitro by cues from more mature cell 
types. However, the effects were different depending on whether terminally or partially 
differentiated cells were applied. Osteoblasts were shown to be more favorable for proliferation 
but not the differentiation of MSCs, while osteocytes significantly stimulated osteogenic 
outcome.
45
 Studies have not been conducted with hMSCs co-cultured with their osteogenically 
committed derivative together with endothelial cells. Although in the current study there were no 
control groups consisting of hMSCs co-cultured with preosteoblasts without HUVECs, the data 
obtained were compared with other co-cultures and monocultures used (as the amount of cells 
were the same) and support a beneficial effect of such a co-culture. Comparing the osteogenically 
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precultured to non-precultured co-cultures, the present study found that the OH and OMH co-
cultures resulted in higher levels of proliferation than the non-osteogenically precultured co-
cultures (MH). Preculture also affected GAG and collagen matrix production and calcium 
content at early time points; however at later time points, the calcium content of the constructs, 
which is the primary marker of osteogenesis, was equal among all co-cultured populations, 
indicating that the preculture period did not significantly affect the co-culture construct 
mineralization.  
The cell proportions in the co-cultures with 1:1 ratios were selected based on the literature,
20, 22, 
40
 and the current study resulted in comparable osteogenic outcomes. Additionally, for 
comparison of the results, several control groups with monocultures of either osteogenically 
precultured cells or hMSCs at lower and higher densities were included. Importantly, both 
seeding densities resulted in inferior osteogenic outcomes than the corresponding co-cultures. 
This suggests that stimulation of osteogenesis observed in co-cultures most likely does not 
reflect the effects of cell density; although it is evidently dependent on cell-to-cell contacts
16, 25
 
and trophic cross-talk.
6
 In direct co-cultures, tight heterotypic cell-to-cell contacts (gap-
junctions) were found between ECs and hMSCs and were thought to contribute toward activation 
of angiogenic and osteogenic gene expression in the cell types, respectively.
16, 25
   
Overall, with regard to construct cellularity and ALP activity, the best outcome (indicated by the 
highest ALP production on a per cell basis) was achieved in the co-cultures with osteogenically 
precultured cells (OH, OMH), which is consistent with longer exposure to osteogenic 
supplements. However, diverse effects were observed in matrix production (collagen, GAGs) 
and maturation (calcium deposition) among the co-cultures investigated. The result that collagen 
and GAG synthetic activity both achieved their maximum observed value in the present study in 
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the co-culture with non-precultured cells (MH) was unexpected, as it indicates osteogenically 
precultured cells effected cell osteogenic synthetic activity in co-cultures relatively less than 
hMSCs. Previously it was shown that the preculture period of MSCs in osteogenic medium 
influences their in vivo bone forming potential.
39
 Perhaps the preculture period of 7 days chosen 
in the present study was not appropriate to achieve positive osteogenic effects exceeding that of 
non-precultured hMSCs. Alternatively, it is possible that the outcome of co-cultures of HUVECs 
and hMSCs depends mostly on endothelial cell activity and their trophic communication with 
progenitor cells, which has not been characterized with respect to the stage of cell maturity. 
Therefore these data demonstrate that supplementation with endothelial cells promotes 
osteogenic differentiation of hMSCs cultured on 3D electrospun PCL microfiber scaffolds 
regardless of their stage of maturity. 
Conclusions 
In this work, we investigated osteogenesis in polymeric microfiber scaffolds using osteogenically 
committed or non-committed hMSCs alone and in combined co-culture with ECs with the goal 
of generating engineered bone constructs. Co-cultures showed lower proliferation but more 
pronounced bone-like matrix formation and mineralization in comparison to hMSC 
monocultures. All co-cultures showed greater degrees of osteogenic differentiation compared to 
monocultures, which suggests the cellular cross-talk in co-cultures enhances the osteogenic 
potential of hMSCs in microfiber scaffolds. Based on these results, we conclude that co-cultures 
of ECs and hMSCs are a promising strategy to improve osteogenesis in engineered bone 
constructs.  
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Figure 1. DNA content at 1, 7, 14, and 21 days of culture in (O1) osteogenically precultured 
hMSCs seeded at 1.5x10
5
 cells per scaffold, (O2) osteogenically precultured hMSCs seeded at 
3.0x10
5
 cells per scaffold, (OH) 1:1 ratio of osteogenically precultured hMSCs and HUVECS 
seeded at 3.0x10
5
 cells per scaffold, (OMH) 1:1:1 ratio of osteogenically precultured hMSCs, 
hMSCs, and HUVECs seeded at 3.0x10
5
 cells per scaffold, (M1) hMSCs seeded at 1.5x10
5
 cells 
per scaffold, (M2) hMSCs seeded at 3.0x10
5
 cells per scaffold, (MH) 1:1 ratio of hMSCs and 
HUVECS seeded at 3.0x10
5
 cells per scaffold, and (H) HUVECs seeded at 1.5x10
5
 cells per 
scaffold. The results are presented as means±SD for n=4. Symbols #, * denote signiﬁcant 
difference of co-cultures from the corresponding monocultures (with lower and higher densities 
respectively), + indicates significant difference of precultured co-cultures (OH, OMH) versus co-
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culture of non-precultured cells (MH), x denotes significant difference between monocultures 
with lower and higher seeding density, ‡ reflects significant difference to the previous time point 
for all groups (p < 0.05).  
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Figure 2. Alkaline phosphatase activity at 1, 7, 14, and 21 days of culture in (O1) osteogenically 
precultured hMSCs seeded at 1.5x10
5
 cells per scaffold, (O2) osteogenically precultured hMSCs 
seeded at 3.0x10
5
 cells per scaffold, (OH) 1:1 ratio of osteogenically precultured hMSCs and 
HUVECS seeded at 3.0x10
5
 cells per scaffold, (OMH) 1:1:1 ratio of osteogenically precultured 
hMSCs, hMSCs, and HUVECs seeded at 3.0x10
5
 cells per scaffold, (M1) hMSCs seeded at 
1.5x10
5
 cells per scaffold, (M2) hMSCs seeded at 3.0x10
5
 cells per scaffold, (MH) 1:1 ratio of 
hMSCs and HUVECS seeded at 3.0x10
5
 cells per scaffold, and (H) HUVECs seeded at 1.5x10
5
 
cells per scaffold.  The results are presented as means±SD for n=4. Symbols #, * denote 
signiﬁcant difference of co-cultures from the corresponding monocultures (with lower and higher 
densities respectively), + indicates significant difference of precultured co-cultures (OH, OMH) 
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versus co-culture of non-precultured cells (MH), x denotes significant difference between 
monocultures with lower and higher seeding density, ‡ reflects significant difference to the 
previous time point for all groups (p < 0.05). 
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Figure 3. Collagen content (A) or normalized collagen content (B) at 7, 14, and 21 days of 
culture in (O1) osteogenically precultured hMSCs seeded at 1.5x10
5
 cells per scaffold, (O2) 
osteogenically precultured hMSCs seeded at 3.0x10
5
 cells per scaffold, (OH) 1:1 ratio of 
osteogenically precultured hMSCs and HUVECS seeded at 3.0x10
5
 cells per scaffold, (OMH) 
1:1:1 ratio of osteogenically precultured hMSCs, hMSCs, and HUVECs seeded at 3.0x10
5
 cells 
per scaffold, (M1) hMSCs seeded at 1.5x10
5
 cells per scaffold, (M2) hMSCs seeded at 3.0x10
5
 
cells per scaffold, (MH) 1:1 ratio of hMSCs and HUVECS seeded at 3.0x10
5
 cells per scaffold, 
and (H) HUVECs seeded at 1.5x10
5
 cells per scaffold. The results are presented as means±SD 
for n=4. Symbols #, * denote signiﬁcant difference of co-cultures from the corresponding 
monocultures (with lower and higher densities respectively), + indicates significant difference of 
precultured co-cultures (OH, OMH) versus co-culture of non-precultured cells (MH), x denotes 
significant difference between monocultures with lower and higher seeding density, ‡ reflects 
significant difference to the previous time point for all groups (p < 0.05). 
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Figure 4. GAG content (A) or normalized GAG content (B) at 7, 14, and 21 days of culture in 
(O1) osteogenically precultured hMSCs seeded at 1.5x10
5
 cells per scaffold, (O2) osteogenically 
precultured hMSCs seeded at 3.0x10
5
 cells per scaffold, (OH) 1:1 ratio of osteogenically 
precultured hMSCs and HUVECS seeded at 3.0x10
5
 cells per scaffold, (OMH) 1:1:1 ratio of 
osteogenically precultured hMSCs, hMSCs, and HUVECs seeded at 3.0x10
5
 cells per scaffold, 
(M1) hMSCs seeded at 1.5x10
5
 cells per scaffold, (M2) hMSCs seeded at 3.0x10
5
 cells per 
scaffold, (MH) 1:1 ratio of hMSCs and HUVECS seeded at 3.0x10
5
 cells per scaffold, and (H) 
HUVECs seeded at 1.5x10
5
 cells per scaffold. The results are presented as means±SD for n=4. 
Symbols #, * denote signiﬁcant difference of co-cultures from the corresponding monocultures 
(with lower and higher densities respectively), + indicates significant difference of precultured 
co-cultures (OH, OMH) versus co-culture of non-precultured cells (MH), x denotes significant 
difference between monocultures with lower and higher seeding density, ‡ reflects significant 
difference to the previous time point for all groups (p < 0.05).  
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Figure 5. Calcium contents at 7, 14, and 21 days of culture in (O1) osteogenically precultured 
hMSCs seeded at 1.5x10
5
 cells per scaffold, (O2) osteogenically precultured hMSCs seeded at 
3.0x10
5
 cells per scaffold, (OH) 1:1 ratio of osteogenically precultured hMSCs and HUVECS 
seeded at 3.0x10
5
 cells per scaffold, (OMH) 1:1:1 ratio of osteogenically precultured hMSCs, 
hMSCs, and HUVECs seeded at 3.0x10
5
 cells per scaffold, (M1) hMSCs seeded at 1.5x10
5
 cells 
per scaffold, (M2) hMSCs seeded at 3.0x10
5
 cells per scaffold, (MH) 1:1 ratio of hMSCs and 
HUVECS seeded at 3.0x10
5
 cells per scaffold, and (H) HUVECs seeded at 1.5x10
5
 cells per 
scaffold.  The results are presented as means±SD for n=4. Symbols #, * denote signiﬁcant 
difference of co-cultures from the corresponding monocultures (with lower and higher densities 
respectively), + indicates significant difference of precultured co-cultures (OH, OMH) versus co-
culture of non-precultured cells (MH), x denotes significant difference between monocultures 
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with lower and higher seeding density, ‡ reflects significant difference to the previous time point 
for all groups (p < 0.05). 
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Figure 6. Bone-like matrix production, maturation, and mineralization within the PCL scaffolds 
with monocultures of hMSCs (M1, M2, O1, O2) and osteogenically precultured co-cultures (OH, 
OMH) or non-precultured co-culture hMSCs (MH) with HUVECs. Three panels display Safranin 
O staining for sulfated GAGs (red), PicroSirius red staining for total collagen (pink) and Von 
Kossa staining for calcium salts (brown). Scale bar represents 100 μm in all images.  
Supplementary Figure S1-S2. Extracellular matrix organization of scaffolds with monocultures 
of hMSCs (M1, M2, O1, O2) and co-cultures of hMSCs with HUVECs (MH, OH and OMH) 
imaged via SEM.  S1 - magnification 100x, scale bar is 500 μm and applies for all images, S2 - 
magnification 2000x, scale bar is 30 μm and applies for all images. Note the absence of the 
matrix and the lack of any mineralization on the scaffolds with endothelial cells (H) although 
cells are still present on the PCL fibers.  
 
 
 
 
  
 Page 37 of 41 
Ti
ss
ue
 E
ng
in
ee
rin
g 
Pa
rt 
A
En
ha
nc
ed
 o
ste
og
en
es
is 
in
 c
o-
cu
ltu
re
s w
ith
 h
um
an
 m
es
en
ch
ym
al
 st
em
 c
el
ls 
an
d 
en
do
th
el
ia
l c
el
ls 
on
 p
ol
ym
er
ic
 m
ic
ro
fib
er
 sc
af
fo
ld
s (
do
i: 1
0.1
08
9/t
en
.T
EA
.20
13
.02
56
)
Th
is 
ar
tic
le
 h
as
 b
ee
n 
pe
er
-re
vi
ew
ed
 a
nd
 a
cc
ep
te
d 
fo
r p
ub
lic
at
io
n,
 b
ut
 h
as
 y
et
 to
 u
nd
er
go
 c
op
ye
di
tin
g 
an
d 
pr
oo
f c
or
re
ct
io
n.
 T
he
 fi
na
l p
ub
lis
he
d 
ve
rs
io
n 
m
ay
 d
iff
er
 fr
om
 th
is 
pr
oo
f.
38 
 
 
 Page 38 of 41
Ti
ss
ue
 E
ng
in
ee
rin
g 
Pa
rt 
A
En
ha
nc
ed
 o
ste
og
en
es
is 
in
 c
o-
cu
ltu
re
s w
ith
 h
um
an
 m
es
en
ch
ym
al
 st
em
 c
el
ls 
an
d 
en
do
th
el
ia
l c
el
ls 
on
 p
ol
ym
er
ic
 m
ic
ro
fib
er
 sc
af
fo
ld
s (
do
i: 1
0.1
08
9/t
en
.T
EA
.20
13
.02
56
)
Th
is 
ar
tic
le
 h
as
 b
ee
n 
pe
er
-re
vi
ew
ed
 a
nd
 a
cc
ep
te
d 
fo
r p
ub
lic
at
io
n,
 b
ut
 h
as
 y
et
 to
 u
nd
er
go
 c
op
ye
di
tin
g 
an
d 
pr
oo
f c
or
re
ct
io
n.
 T
he
 fi
na
l p
ub
lis
he
d 
ve
rs
io
n 
m
ay
 d
iff
er
 fr
om
 th
is 
pr
oo
f.
39 
 
Supplementary Figure S1. Extracellular matrix organization of scaffolds with monocultures of 
hMSCs (M1, M2, O1, O2) and co-cultures of hMSCs with HUVECs (MH, OH and OMH) 
imaged via SEM.  S1 - magnification 100x, scale bar is 500 μm and applies for all images, S2 - 
magnification 2000x, scale bar is 30 μm and applies for all images. Note the absence of the 
matrix and the lack of any mineralization on the scaffolds with endothelial cells (H) although 
cells are still present on the PCL fibers. 
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Supplementary Figure S2. Extracellular matrix organization of scaffolds with monocultures of 
hMSCs (M1, M2, O1, O2) and co-cultures of hMSCs with HUVECs (MH, OH and OMH) 
imaged via SEM.  S1 - magnification 100x, scale bar is 500 μm and applies for all images, S2 - 
magnification 2000x, scale bar is 30 μm and applies for all images. Note the absence of the 
matrix and the lack of any mineralization on the scaffolds with endothelial cells (H) although 
cells are still present on the PCL fibers. 
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